Immix Biopharma (IMMX) Interest & Investment Income (2023 - 2026)
Immix Biopharma's (IMMX) quarterly Interest & Investment Income came in at $717168.0 in Q1 2026, up 377.41% year-on-year from $150219.0 in Q1 2025, and up 230.93% quarter-over-quarter from $216712.0 in Q4 2025.
Immix Biopharma (IMMX) Interest & Investment Income (2023 - 2026) Analysis & Trends
Immix Biopharma has disclosed Interest & Investment Income across 4 years of filings, most recently posting $717168.0 for Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $717168.0, up 377.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (up 24.77% YoY), and the FY2025 annual result was $555526.0, down 45.4% from the prior year.
- Interest & Investment Income came in at $717168.0 for Q1 2026 at Immix Biopharma, up from $216712.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $717168.0 in Q1 2026 to a low of $27892.0 in Q1 2023.
- The 4-year median for Interest & Investment Income is $186691.0 (2023), against an average of $220158.0.
- Across the five-year window, Interest & Investment Income soared 860.52% in 2024 and sank 67.06% in 2025, its largest moves.
- Immix Biopharma's Interest & Investment Income stood at $228575.0 in 2023, then fell by 18.69% to $185851.0 in 2024, then increased by 16.61% to $216712.0 in 2025, then surged by 230.93% to $717168.0 in 2026.
- The last three Interest & Investment Income figures came in at $717168.0 (Q1 2026), $216712.0 (Q4 2025), and $84539.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -14.79 Mn |
| 10 | Immix Biopharma | 467.59 Mn | 467.59 Mn | - | 717,168.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 717,168.00 |
| Dec 31, 2025 | 216,712.00 |
| Sep 30, 2025 | 84,539.00 |
| Jun 30, 2025 | 104,056.00 |
| Mar 31, 2025 | 150,219.00 |
| Dec 31, 2024 | 185,851.00 |
| Sep 30, 2024 | 256,680.00 |
| Jun 30, 2024 | 306,915.00 |
| Mar 31, 2024 | 267,908.00 |
| Dec 31, 2023 | 228,575.00 |
| Sep 30, 2023 | 186,691.00 |
| Jun 30, 2023 | 128,848.00 |
| Mar 31, 2023 | 27,892.00 |